Treatment with a brain cancer vaccine followed by antineoplastic chemotherapy results in synergistic clinical effects in patients with de novo glioblastoma multiforme

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1460, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Impact of Adjuvant Chemotherapy in Glioblastoma Multiforme: A Meta-Analysis

By Spiegel Brennan M.R.   Esrailian Eric   Laine Loren  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 775-787

Adis International

Access to resources Recommend Favorite

Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

By  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2926-2932

Blackwell Publishing

Access to resources Recommend Favorite

Mucocutaneous side effects of antineoplastic chemotherapy

By Guillot B   Bessis D   Dereure O  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 579-587

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme

By Martikainen Janne A.  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 803-815

Adis International

Access to resources Recommend Favorite

Novel chemotherapeutic agents for the treatment of glioblastoma multiforme

By Jendrossek Verena   Belka Claus   Bamberg Michael  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1899-1924

Informa Healthcare

Access to resources Recommend Favorite